New features of the PCDx Test (Paradigm Cancer Diagnostic Test)
There are 2 new features, which make the PCDx test even better: As of now it is possible to perform an IHC (immunohistochemistry) for PD-L1 with the clone SP142. PD-L1 SP142 is the companion diagnostic for the immune-checkpoint-inhbitor Atezolizumab. Atezolizumab is applied in breast cancer, non-...